Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
GILEAD Sciences Inc was ordered by a jury to pay Merck & Co US$200 million for patent infringement over a drug compound that cures hepatitis C, a tenth of what Merck sought.
The verdict announced on Thursday follows an earlier finding by the jury embracing Merck's